NEURACAP

Health Care research and M&A coverage

Sector outlooks and M&A updates for 36 industries: how the market prices them, which comparables set the range, and what has transacted.

For information only. Not an appraisal or a fairness opinion.

Reports by industry

Antibody and Protein Therapeutics

Biotechnology

Cardiovascular Devices

Cell and Gene Therapies

Clinical Laboratory Services

Contract Development and Manufacturing (CDMO)

Contract Research Organizations (CRO)

Diagnostic and Testing Equipment

Digital Health and Telehealth

Generic and Non-Prescription Drugs

Genetic and Screening Services

Health Care Data and Analytics

Health Care Distributors

Health Care Equipment and Supplies

Health Care Workforce Services

Health Insurance and Benefits Management

Home Health and Long-Term Care

Hospitals and Health Systems

Immunology and Inflammation Therapeutics

Life Sciences Research Reagents and Supplies

Life Sciences Tools and Instruments

Managed Health Care

Medical Devices

Medical Imaging Equipment

Neurology and CNS Therapeutics

Oncology Therapeutics

Ophthalmic Therapeutics

Outpatient and Specialty Care Services

Pharmaceuticals

Rare and Orphan Disease Therapeutics

Regenerative Medicine

Specialty and Branded Pharmaceuticals

Surgical and Orthopedic Devices

Therapeutic and Monitoring Devices

Therapeutic Discovery Platforms

Vaccines

Company valuation reports are listed on the company reports page.

Need coverage on a company in Health Care?

Company valuation reports run the same method against a single business, public or private.